Clinical Trials for Reducing Cardiovascular Mortality (original) (raw)
Angiotensin Receptor–Neprilysin Inhibitors and the Natriuretic Peptide Axis
Nestor Vasquez
Current Heart Failure Reports, 2020
View PDFchevron_right
Current role of neprilysin inhibitors in hypertension and heart failure
Dan Atar
Pharmacology & Therapeutics, 2014
View PDFchevron_right
Angiotensin receptor neprilysin inhibitor as a novel antihypertensive drug: Evidence from Asia and around the globe
Apichard Sukonthasarn
The Journal of Clinical Hypertension, 2020
View PDFchevron_right
The Angiotensin Receptor Neprilysin Inhibitor LCZ696 in Heart Failure with Preserved Ejection Fraction: A Phase II Randomised-Controlled Trial
Amil Shah, Dan Atar
Journal of Cardiac Failure, 2012
View PDFchevron_right
Neprilysin: A Potential Therapeutic Target of Arterial Hypertension?
Wheeler Torres
Current Cardiology Reviews
View PDFchevron_right
Angiotensin Receptor Neprilysin Inhibition in Heart Failure: Mechanistic Action and Clinical Impact
Inder Anand
Journal of cardiac failure, 2015
View PDFchevron_right
The Renin-Angiotensin System, Capri 2005
Renata Cifkova
High Blood Pressure & Cardiovascular Prevention, 2005
View PDFchevron_right
Biochemistry, Therapeutics, and Biomarker Implications of Neprilysin in Cardiorenal Disease
John Burnett
Clinical chemistry, 2017
View PDFchevron_right
Effect of Neprilysin Inhibition on Various Natriuretic Peptide Assays
Shreya Shrestha
Journal of the American College of Cardiology, 2019
View PDFchevron_right
Angiotensin receptor-neprilysin inhibitors: clinical potential in heart failure and beyond
jagdeep singh
Vascular Health and Risk Management, 2015
View PDFchevron_right
Review On A Novel Dual Acting Angiotensin Receptor-Neprilysin Inhibitor(ARNI): Potential Benefits In Heart Failure And Reduced Ejection Fraction(HFREF
IOSR Journals
View PDFchevron_right
A REVIEW ON GLOBAL TRENDS IN HEART FAILURE AND EVOLUTION OF ANGIOTENSIN-NEPRILYSIN INHIBITOR
Asian Journal of Pharmaceutical and Clinical Research Journal
Asian Journal of Pharmaceutical and Clinical Research, 2020
View PDFchevron_right
Utility of natriuretic peptides to assess and manage patients with heart failure receiving angiotensin receptor blocker/neprilysin inhibitor therapy
Sheryl Chow
Postgraduate Medicine, 2018
View PDFchevron_right
Impact of prolonged utilization of neprilysin inhibition on the cognitive function of heart failure patients
Pratik Shah
Therapeutic advances in cardiovascular disease, 2018
View PDFchevron_right
Angiotensin receptor-neprilysin inhibitor improves New York Heart Association class and N-terminal-pro B-type natriuretic peptide levels: initial experience in a Singapore single-centre cohort
Natalie Koh
Singapore Medical Journal, 2021
View PDFchevron_right
Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
Carlos Flores
View PDFchevron_right
The Power and Promise of Angiotensin Receptor Neprilysin Inhibitor (ARNI) in Heart Failure Management: National Consensus Statement
SATYANARAYAN ROUTRAY
Journal of Association of Physicians of India, 2023
View PDFchevron_right
Use of angiotensin receptor – neprilysin inhibitors in heart failure: a paradigm shift
M IRHUMA
South African Family Practice
View PDFchevron_right
Angiotensin Receptor Neprilysin Inhibitor [ARNI] and Its Implications Ejection Fraction Preserved Heart Failure: A Recent Review
Alokita Trivedi
Journal of Pharmaceutical Research International
View PDFchevron_right
Angiotensin receptor neprilysin inhibitor in heart failure with reduced ejection fraction: Real-world experience from a safety perspective
Roopali Khanna
Journal of Indian College of Cardiology, 2020
View PDFchevron_right
Independence of the blood pressure lowering effect and efficacy of the angiotensin receptor neprilysin inhibitor, LCZ696, in patients with heart failure with preserved ejection fraction: an analysis of the PARAMOUNT trial
Toni Bransford
European Journal of Heart Failure, 2014
View PDFchevron_right
The Effctiveness Of Angiotensin Receptor Neprilysin Inhibitor On Improving The Cardiac Remodelling Compared To Ace-Inhibitor On Patients With Chronic Heart Failure
Muhammad Maulana
Indonesian Journal of Pharmaceutical and Clinical Research
View PDFchevron_right